I wish that was true, but who knows.
IMO management know Zantrene works and is safe, but it has to be proven for various indications to FDA standards and tbat takes time.
If I was management I would look at the release of the data on the various indications to come out close together. I am not talking about withholding market information but just a bit of program timing. That will put us in the box seat for licence or takeover negotiations and maximise sh value.
gltah
General Comments / Chat, page-6444
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.000(0.00%) |
Mkt cap ! $247.1M | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.45 | $1.35 | $254.2K | 185.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 212 | $1.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 5981 | 3 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |